Julie Spellman Sweet - 17 Jan 2025 Form 4 Insider Report for Accenture plc (ACN)

Role
Chair and CEO, Director
Signature
/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet
Issuer symbol
ACN
Transactions as of
17 Jan 2025
Net transactions value
-$885,143
Form type
4
Filing time
21 Jan 2025, 09:12:05 UTC
Previous filing
06 Jan 2025
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACN Class A ordinary shares Sale $496,442 -1,402 -4.5% $354.10 29,961 17 Jan 2025 Direct F1, F2
transaction ACN Class A ordinary shares Sale $360,945 -1,017 -3.4% $354.91 28,944 17 Jan 2025 Direct F1, F3
transaction ACN Class A ordinary shares Sale $27,756 -78 -0.27% $355.84 28,866 17 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.
F2 The transaction was executed in multiple trades at prices ranging from $353.51 to $354.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The transaction was executed in multiple trades at prices ranging from $354.53 to $355.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.